Additional Advances in Biliary Tract Cancer Research and Advocacy With Melinda Bachini

Name: Additional Advances in Biliary Tract Cancer Research and Advocacy With Melinda Bachini
Uploaded: 2026-02-19T14:23:36.107+00:00
Duration: 11 min 58 s
Description: Biliary tract cancers (BTCs), including cholangiocarcinoma, remain among the most complex and aggressive malignancies encountered in oncology practice.

Biliary tract cancers (BTCs), including cholangiocarcinoma, remain among the most complex and aggressive malignancies encountered in oncology practice. Melinda Bachini, the Chief Patient Officer at the Cholangiocarcinoma Foundation and a 16‑year survivor of stage IV intrahepatic cholangiocarcinoma, recently served as a member of i3 Health’s Multidisciplinary Task Force activity, Challenges and Innovations in Biliary Tract Cancer: A Multidisciplinary Task Force Perspective . In this follow-up interview in honor of World Cholangiocarcinoma Day, she shared further insights into her experiences as a patient and advocate, the importance of clinical trials, and the power of advocacy in the cholangiocarcinoma community.